Inflamed Joints and Stiff Arteries
نویسندگان
چکیده
منابع مشابه
Inflamed joints and stiff arteries: is rheumatoid arthritis a cardiovascular risk factor?
Patients with rheumatoid arthritis (RA) are at increased risk of cardiovascular events, with an estimated 70% excess mortality rate that can be ascribed to cardiovascular causes in up to 50% of cases.1,2 A 3-fold-increased adjusted risk of myocardial infarction has been reported, particularly in subjects with longer disease duration.3 This has prompted recommendations that RA be considered an i...
متن کاملThe Treatment of Stiff Joints
A man, woman, or child breaks an arm or sustains an injury in or in the neighbourhood of a joint. After a longer or shorter period of immobilisation according to the therapeutic leanings of the particular surgeon or physician who has been called in to the sufferer, a degree of stiffness sets in in the neighbourhood of the joint. The time is now ripe for the medical attendant to do what he calls...
متن کاملCompartment syndrome, stiff joints, and diabetic cheiroarthropathy.
Sir: The abnormality in collagen metabolism in diabetes is characterised by unusually stable, excessively cross linked fibrils. Nonenzymatic glycosylation may be partly responsible for the stiffness of diabetic collagen,' and such changes may relate to development of the microvascular complications of nephropathy and retinopathy as well as cheiroarthropathy. Microvascular complications occur mo...
متن کاملThe benefits of inflamed arteries
Like the first draft of a term paper, the antibody genes of some B cells require revisions. On page 2985, Panigrahi et al. show that this genetic editing is faulty in patients with two kinds of autoimmune disease. The results could lead to new tests and refined treatments for these diseases. During development in the bone marrow, maturing B cells reshuffle their antibody genes to fashion defens...
متن کاملPreferential accumulation of meloxicam in inflamed synovial joints of dogs.
MELOXICAM is a NSAID classified as a derivative of enolic acid, licensed to treat acute and chronic musculoskeletal disorders in the dog. Meloxicam achieves maximal plasma concentration 4.5 hours after oral administration, has a low volume of distribution (0.3 l/kg), is highly plasma protein bound (97 per cent) and has an elimination half-life of 24 hours in dogs (EMA 2011). Steady state pharma...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2006
ISSN: 0009-7322,1524-4539
DOI: 10.1161/circulationaha.106.648139